Overview Financials News + Filings Key Docs Charts Insiders
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
Tags Quarterly results Director departure
|
RBC LIFE SCIENCES, INC. (RBCL)
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
02/09/2016 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
12/21/2015 |
8-K
| Quarterly results |
11/16/2015 |
10-Q
| Quarterly Report for the period ended September 30, 2015 |
08/14/2015 |
10-Q
| Quarterly Report for the period ended June 30, 2015 |
07/21/2015 |
8-K
| Completion of Acquisition or Disposition of Assets, Financial Statements and Exhibits |
06/30/2015 |
8-K
| Resignation/termination of a director |
06/03/2015 |
8-K
| Entry into a Material Definitive Agreement, Financial Statements and Exhibits |
05/14/2015 |
10-Q
| Quarterly Report for the period ended March 31, 2015 |
04/28/2015 |
DEF 14A
| Form DEF 14A - Other definitive proxy statements: |
03/31/2015 |
10-K
| Annual Report for the period ended December 31, 2014 |
02/06/2015 |
SC 13G/A
| ABRAHAMSON PETER JOHN reports a 6.4% stake in RBC Life Sciences, Inc. |
01/05/2015 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
11/12/2014 |
10-Q
| Quarterly Report for the period ended September 30, 2014 |
10/23/2014 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
10/21/2014 |
4
| HOWARD CLINTON H (CEO) has filed a Form 4 on RBC LIFE SCIENCES, INC. |
10/01/2014 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
09/19/2014 |
SC 13G
| ABRAHAMSON PETER JOHN reports a 5.4% stake in RBC Life Sciences, Inc. |
08/28/2014 |
8-K
| Entry into a Material Definitive Agreement, Financial Statements and Exhibits |
08/14/2014 |
8-K
| Quarterly results
Docs:
|
"RBC Life Sciences Reports Second Quarter Results Irving, Texas, August 14, 2014 - RBC Life Sciences, Inc. , a provider of proprietary nutritional supplements, and wound care and pain management products, today reported consolidated net sales of $7.9 million for the quarter ended June 30, 2014, an 18% increase over net sales of $6.7 million in the second quarter of 2013. The Company reported a second quarter net loss of $7,000, or $0.00 per share, compared to a net loss of $147,000, or $0.07 per share, for the same quarter last year. Net sales were $13.6 million for the six months ended June 30, 2014, a 10% increase over net sales of $12.4 million in the same period last year. For the six months ended June 30, 2014 the Company reported a net loss of $385,000, or $0.17 per share, compared to..." |
|
08/14/2014 |
10-Q
| Quarterly Report for the period ended June 30, 2014 |
06/20/2014 |
8-K
| Submission of Matters to a Vote of Security Holders |
06/18/2014 |
4
| HOWARD CLINTON H (CEO) has filed a Form 4 on RBC LIFE SCIENCES, INC. |
06/18/2014 |
4
| HOWARD CLINTON H (CEO) has filed a Form 4 on RBC LIFE SCIENCES, INC. |
06/12/2014 |
8-K
| Other Events |
06/04/2014 |
4
| HOWARD CLINTON H (CEO) has filed a Form 4 on RBC LIFE SCIENCES, INC. |
06/04/2014 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
05/14/2014 |
8-K
| Quarterly results
Docs:
|
"RBC Life Sciences Reports First Quarter Results Irving, Texas, May 14, 2014 - RBC Life Sciences, Inc. , a provider of proprietary nutritional supplements, and wound care and pain management products, today reported consolidated net sales of $5.7 million for the first quarter of 2014, which was flat compared to the first quarter of 2013. For the first quarter of 2014, the Company reported a net loss of $378,000, or $0.17 per share, compared to a net loss of $8,000, or $0.00 per share, for the same quarter last year. All per share amounts have been restated to reflect the 1-for-500 reverse stock split and the 50-for-1 forward stock split implemented on August 9, 2013. “Net sales of Nutritional Products during the first quarter decreased by approximately 5%, due to decreased shipments to our ..." |
|
05/14/2014 |
10-Q
| Quarterly Report for the period ended March 31, 2014 |
04/29/2014 |
DEF 14A
| Form DEF 14A - Other definitive proxy statements |
04/03/2014 |
8-K
| Termination of a Material Definitive Agreement |
03/31/2014 |
4
| Philipp Joseph P (Director) has filed a Form 4 on RBC LIFE SCIENCES, INC. |
03/27/2014 |
8-K
| Quarterly results |
03/27/2014 |
10-K
| Annual Report for the period ended December 31, 2013 |
01/09/2014 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
|
|
|